Evaluate Ltd. will release a report on the Orphan Drug sector on Tuesday, April 23rd at the 2013 BIO International Convention. The report, which is based on EvaluatePharma® data complemented by commentary from EP Vantage, provides a strategic view of the Orphan Drug sector.